Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems
- PMID: 19150491
- DOI: 10.1016/j.ijpharm.2008.12.024
Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems
Abstract
The purpose of this work was to propose a drug delivery system based on a biodegradable porous membrane, whose surface is covered by a nanoparticle film, thus achieving a controlled drug release rate. Furthermore, due to the fact that the assembly of the system is performed in aqueous medium, contact with organic solvents is avoided. The method is performed in two steps: (i) preparation of biodegradable porous membranes (by a solvent casting and particulate leaching technique) and biodegradable nanoparticles (by the emulsification-diffusion method), extensively eliminating the solvent in both of them; (ii) infiltration into membranes of an aqueous solution of a model drug (carbamazepine) and a nanoparticle dispersion. In both cases, poly(DL-lactic-co-glycolic acid) (PLGA 50:50) was used as a biodegradable polymer. Carbamazepine adsorbed onto biodegradable porous membranes shows an immediate release behavior (95% released in <15 min). Infiltration of different amounts of nanoparticles (50, 100, 400 and 600 mg of nanoparticles/0.625 g of membrane) into biodegradable porous membranes shows a Fickian diffusion according to Peppas model, and fits Higuchi's model. This behavior was attributed to the diffusional barrier constituted by the nanoparticle film. As expected, the carbamazepine release rate was dependent on the amount of infiltrated/adsorbed nanoparticles into biodegradable porous membrane. DSC studies show molecular dispersion of the drug throughout the membrane.
Similar articles
-
Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.Int J Pharm. 2004 Jul 8;278(2):293-301. doi: 10.1016/j.ijpharm.2004.03.032. Int J Pharm. 2004. PMID: 15196634
-
Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.Int J Pharm. 2007 May 24;336(2):367-75. doi: 10.1016/j.ijpharm.2006.11.061. Epub 2006 Dec 5. Int J Pharm. 2007. PMID: 17207944
-
Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.Eur J Pharm Biopharm. 2007 Apr;66(1):34-41. doi: 10.1016/j.ejpb.2006.09.004. Epub 2006 Sep 22. Eur J Pharm Biopharm. 2007. PMID: 17070678
-
Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform.J Microencapsul. 2012;29(1):54-62. doi: 10.3109/02652048.2011.629745. Epub 2011 Oct 31. J Microencapsul. 2012. PMID: 22034956 Review.
-
Biodegradable polymeric nanoparticles based drug delivery systems.Colloids Surf B Biointerfaces. 2010 Jan 1;75(1):1-18. doi: 10.1016/j.colsurfb.2009.09.001. Epub 2009 Sep 8. Colloids Surf B Biointerfaces. 2010. PMID: 19782542 Review.
Cited by
-
Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses.Materials (Basel). 2021 Jun 10;14(12):3197. doi: 10.3390/ma14123197. Materials (Basel). 2021. PMID: 34200640 Free PMC article. Review.
-
A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.Int J Nanomedicine. 2013;8:2141-51. doi: 10.2147/IJN.S44482. Epub 2013 Jun 10. Int J Nanomedicine. 2013. PMID: 23788833 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials